
Scientists are in the process of developing drugs which aim at diseases that are undruggable.
They are the hundreds of thousands of proteins that many scientists considered to be "undruggable," meaning that previous efforts to develop a drug against them had failed.
Advertisement
The advances could lead to a new generation of medicines for treating cancer, diabetes, and other major diseases, they said.
In one advance, a drug called stabled peptides was able to block a key protein that's involved in the development of cancer. The peptides prevented the growth of cancer cells in a group of test animals.
"Stapled peptides represent an entirely new class of potential drugs. They herald a new era in the drug-discovery world," said Gregory Verdine.
Until now, only a tiny fraction of hundreds of thousands of proteins in the human body were considered "druggable." Thanks to a new generation of drug discovery technologies, that tiny fraction is now on the rise.
In addition to "stapled peptides," scientists described new insights into how proteins interact with other proteins, the use of small molecules to target and treat cancer.
Source: ANI
Advertisement
"Stapled peptides represent an entirely new class of potential drugs. They herald a new era in the drug-discovery world," said Gregory Verdine.
Until now, only a tiny fraction of hundreds of thousands of proteins in the human body were considered "druggable." Thanks to a new generation of drug discovery technologies, that tiny fraction is now on the rise.
In addition to "stapled peptides," scientists described new insights into how proteins interact with other proteins, the use of small molecules to target and treat cancer.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News

The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.

The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.

Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.

Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.

In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.